The FDA commissioner is scheduled to testify at a hearing before the U.S. House of Representatives Committee on Oversight and Accountability next week.

Commissioner Robert Califf is the only witness scheduled for the hearing, which is set for 1 p.m. EDT on April 11. The hearing will be open to

Continue Reading FDA leader called to testify about food safety before congressional committee

–OPINION —

House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA), Ranking Member Frank Pallone Jr. (D-NJ), Subcommittee on Health Chair Brett Guthrie (R-KY) and Ranking Member Anna G. Eshoo (D-CA), and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA) and Ranking Member Kathy Castor (D-FL) wrote to

Continue Reading Publisher’s Platform: Representatives demand FDA action on lead-tainted cinnamon applesauce

The FDA has released extensive information about the status of its work to improve its monitoring of infant formula production and its handling of complaints about the safety of formula.

Problems with the Food and Drug Administration’s ability to watch for problems and respond to complaints about infant formula were

Continue Reading FDA revises organization, adds staff to address problems with infant formula

Time is on my side, yes it is . . .”

Written by Jerry Ragovoy performed by The Rolling Stones

Nothing could be further from the truth than that song lyric regarding the work ahead for the first-ever deputy commissioner for human food at the Food and Drug Administration.

During

Continue Reading Beach Beat: A round table discussion with FDA’s new deputy commissioner for foods

The Food and Drug Administration’s first Deputy Commissioner for Human Foods, Jim Jones, started his work yesterday and sent the below letter to colleagues.

FDA Commissioner Robert Calif appointed Jones after the agency’s embarrassing turmoil over the lack of a clear chain of command on the food side of its

Continue Reading New FDA administrator says he is ready to cooperate to restructure the agency

The head of the Food and Drug Administration says his evolving plan to restructure the food side of the agency is moving forward with changes planned for regulatory affairs, but two key observers say the movement falls short of necessary steps to ensure the effectiveness of the reorganization.

FDA Commissioner

Continue Reading Some question the FDA commissioner’s plan for the reorganization of the agency’s regulatory office